 | • レポートコード：QYR9ST02656 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の血清がんバイオマーカー市場について調査・分析し、以下の構成でお届け致します。血清がんバイオマーカーの種類別には、肝細胞がん血清バイオマーカー、肺がん血清バイオマーカー、膵臓及び胆道がん血清バイオマーカー、乳がん血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他に、用途別には、病院、学術研究所、外来手術センター、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別血清がんバイオマーカー売上データ ・地域別血清がんバイオマーカー市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別血清がんバイオマーカー市場規模：肝細胞がん血清バイオマーカー、肺がん血清バイオマーカー、膵臓及び胆道がん血清バイオマーカー、乳がん血清バイオマーカー、神経膠芽腫血清バイオマーカー、その他 ・用途別血清がんバイオマーカー市場規模：病院、学術研究所、外来手術センター、その他 ・主要メーカーの企業情報：Roche、Pfizer、Novartis、Abbott、BD、Merck、Eli Lilly、Agilent Technologies、Boehringer Ingelheim、AstraZeneca、Bristol-Myers Squibb、Novo Nordisk、Allergan、Gilead ・血清がんバイオマーカーの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Serum biomarkers are proteins generally detected in urine, blood, and other bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within high risk population, diagnosis of specific type of cancer, prediction in its growth, screen its treatment response, and detect early recurrence.The global serum cancer biomarkers market is projected to grow at a rapid pace in the next few years. Key drivers of the market are increase in the number of people suffering from different types of cancer and rise in the geriatric population. Increase in the cancer-afflicted population is anticipated to be another key driver of the market.
The global Serum Cancer Biomarkers market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Serum Cancer Biomarkers market based on company, product type, end user and key regions.
This report studies the global market size of Serum Cancer Biomarkers in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Serum Cancer Biomarkers in these regions.
This research report categorizes the global Serum Cancer Biomarkers market by top players/brands, region, type and end user. This report also studies the global Serum Cancer Biomarkers market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Roche
Pfizer
Novartis
Abbott
BD
Merck
Eli Lilly
Agilent Technologies
Boehringer Ingelheim
AstraZeneca
Bristol-Myers Squibb
Novo Nordisk
Allergan
Gilead
Market size by Product
Hepatocellular Carcinoma Serum Biomarkers
Lung Cancer Serum Biomarkers
Pancreatic & Biliary Tract Cancer Serum Biomarkers
Breast Cancer Serum Biomarkers
Glioblastoma Serum Biomarkers
Others
Market size by End User
Hospitals
Academic & Research Institutes
Ambulatory Surgical Centers
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Serum Cancer Biomarkers market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Serum Cancer Biomarkers market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Serum Cancer Biomarkers companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Serum Cancer Biomarkers submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Serum Cancer Biomarkers are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Serum Cancer Biomarkers market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Serum Cancer Biomarkers Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Serum Cancer Biomarkers Market Size Growth Rate by Product
1.4.2 Hepatocellular Carcinoma Serum Biomarkers
1.4.3 Lung Cancer Serum Biomarkers
1.4.4 Pancreatic & Biliary Tract Cancer Serum Biomarkers
1.4.5 Breast Cancer Serum Biomarkers
1.4.6 Glioblastoma Serum Biomarkers
1.4.7 Others
1.5 Market by End User
1.5.1 Global Serum Cancer Biomarkers Market Size Growth Rate by End User
1.5.2 Hospitals
1.5.3 Academic & Research Institutes
1.5.4 Ambulatory Surgical Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Serum Cancer Biomarkers Market Size
2.1.1 Global Serum Cancer Biomarkers Revenue 2014-2025
2.1.2 Global Serum Cancer Biomarkers Sales 2014-2025
2.2 Serum Cancer Biomarkers Growth Rate by Regions
2.2.1 Global Serum Cancer Biomarkers Sales by Regions
2.2.2 Global Serum Cancer Biomarkers Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Serum Cancer Biomarkers Sales by Manufacturers
3.1.1 Serum Cancer Biomarkers Sales by Manufacturers
3.1.2 Serum Cancer Biomarkers Sales Market Share by Manufacturers
3.1.3 Global Serum Cancer Biomarkers Market Concentration Ratio (CR5 and HHI)
3.2 Serum Cancer Biomarkers Revenue by Manufacturers
3.2.1 Serum Cancer Biomarkers Revenue by Manufacturers (2014-2019)
3.2.2 Serum Cancer Biomarkers Revenue Share by Manufacturers (2014-2019)
3.3 Serum Cancer Biomarkers Price by Manufacturers
3.4 Serum Cancer Biomarkers Manufacturing Base Distribution, Product Types
3.4.1 Serum Cancer Biomarkers Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Serum Cancer Biomarkers Product Type
3.4.3 Date of International Manufacturers Enter into Serum Cancer Biomarkers Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Serum Cancer Biomarkers Sales by Product
4.2 Global Serum Cancer Biomarkers Revenue by Product
4.3 Serum Cancer Biomarkers Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Serum Cancer Biomarkers Breakdown Data by End User
6 North America
6.1 North America Serum Cancer Biomarkers by Countries
6.1.1 North America Serum Cancer Biomarkers Sales by Countries
6.1.2 North America Serum Cancer Biomarkers Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Serum Cancer Biomarkers by Product
6.3 North America Serum Cancer Biomarkers by End User
7 Europe
7.1 Europe Serum Cancer Biomarkers by Countries
7.1.1 Europe Serum Cancer Biomarkers Sales by Countries
7.1.2 Europe Serum Cancer Biomarkers Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Serum Cancer Biomarkers by Product
7.3 Europe Serum Cancer Biomarkers by End User
8 Asia Pacific
8.1 Asia Pacific Serum Cancer Biomarkers by Countries
8.1.1 Asia Pacific Serum Cancer Biomarkers Sales by Countries
8.1.2 Asia Pacific Serum Cancer Biomarkers Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Serum Cancer Biomarkers by Product
8.3 Asia Pacific Serum Cancer Biomarkers by End User
9 Central & South America
9.1 Central & South America Serum Cancer Biomarkers by Countries
9.1.1 Central & South America Serum Cancer Biomarkers Sales by Countries
9.1.2 Central & South America Serum Cancer Biomarkers Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Serum Cancer Biomarkers by Product
9.3 Central & South America Serum Cancer Biomarkers by End User
10 Middle East and Africa
10.1 Middle East and Africa Serum Cancer Biomarkers by Countries
10.1.1 Middle East and Africa Serum Cancer Biomarkers Sales by Countries
10.1.2 Middle East and Africa Serum Cancer Biomarkers Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Serum Cancer Biomarkers by Product
10.3 Middle East and Africa Serum Cancer Biomarkers by End User
11 Company Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Company Business Overview
11.1.3 Roche Serum Cancer Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Roche Serum Cancer Biomarkers Products Offered
11.1.5 Roche Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Company Business Overview
11.2.3 Pfizer Serum Cancer Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Pfizer Serum Cancer Biomarkers Products Offered
11.2.5 Pfizer Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Serum Cancer Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Serum Cancer Biomarkers Products Offered
11.3.5 Novartis Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Company Business Overview
11.4.3 Abbott Serum Cancer Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Abbott Serum Cancer Biomarkers Products Offered
11.4.5 Abbott Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 Company Business Overview
11.5.3 BD Serum Cancer Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.5.4 BD Serum Cancer Biomarkers Products Offered
11.5.5 BD Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Company Business Overview
11.6.3 Merck Serum Cancer Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Merck Serum Cancer Biomarkers Products Offered
11.6.5 Merck Recent Development
11.7 Eli Lilly
11.7.1 Eli Lilly Company Details
11.7.2 Company Business Overview
11.7.3 Eli Lilly Serum Cancer Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Eli Lilly Serum Cancer Biomarkers Products Offered
11.7.5 Eli Lilly Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Company Business Overview
11.8.3 Agilent Technologies Serum Cancer Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Agilent Technologies Serum Cancer Biomarkers Products Offered
11.8.5 Agilent Technologies Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Company Business Overview
11.9.3 Boehringer Ingelheim Serum Cancer Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Boehringer Ingelheim Serum Cancer Biomarkers Products Offered
11.9.5 Boehringer Ingelheim Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 Company Business Overview
11.10.3 AstraZeneca Serum Cancer Biomarkers Sales, Revenue and Gross Margin (2014-2019)
11.10.4 AstraZeneca Serum Cancer Biomarkers Products Offered
11.10.5 AstraZeneca Recent Development
11.11 Bristol-Myers Squibb
11.12 Novo Nordisk
11.13 Allergan
11.14 Gilead
12 Future Forecast
12.1 Serum Cancer Biomarkers Market Forecast by Regions
12.1.1 Global Serum Cancer Biomarkers Sales Forecast by Regions 2019-2025
12.1.2 Global Serum Cancer Biomarkers Revenue Forecast by Regions 2019-2025
12.2 Serum Cancer Biomarkers Market Forecast by Product
12.2.1 Global Serum Cancer Biomarkers Sales Forecast by Product 2019-2025
12.2.2 Global Serum Cancer Biomarkers Revenue Forecast by Product 2019-2025
12.3 Serum Cancer Biomarkers Market Forecast by End User
12.4 North America Serum Cancer Biomarkers Forecast
12.5 Europe Serum Cancer Biomarkers Forecast
12.6 Asia Pacific Serum Cancer Biomarkers Forecast
12.7 Central & South America Serum Cancer Biomarkers Forecast
12.8 Middle East and Africa Serum Cancer Biomarkers Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Serum Cancer Biomarkers Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Serum Cancer Biomarkers Product Picture
Table Serum Cancer Biomarkers Market Segments
Table Key Manufacturers Serum Cancer Biomarkers Covered
Table Global Serum Cancer Biomarkers Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Serum Cancer Biomarkers Sales Market Share by Product 2014-2025
Figure Hepatocellular Carcinoma Serum Biomarkers Product Picture
Table Major Manufacturers of Hepatocellular Carcinoma Serum Biomarkers
Figure Lung Cancer Serum Biomarkers Product Picture
Table Major Manufacturers of Lung Cancer Serum Biomarkers
Figure Pancreatic & Biliary Tract Cancer Serum Biomarkers Product Picture
Table Major Manufacturers of Pancreatic & Biliary Tract Cancer Serum Biomarkers
Figure Breast Cancer Serum Biomarkers Product Picture
Table Major Manufacturers of Breast Cancer Serum Biomarkers
Figure Glioblastoma Serum Biomarkers Product Picture
Table Major Manufacturers of Glioblastoma Serum Biomarkers
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Serum Cancer Biomarkers Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Hospitals
Figure Academic & Research Institutes
Figure Ambulatory Surgical Centers
Figure Others
Figure Serum Cancer Biomarkers Report Years Considered
Figure Global Serum Cancer Biomarkers Market Size 2014-2025 (Million US$)
Figure Global Serum Cancer Biomarkers Sales 2014-2025 (K Units)
Table Global Serum Cancer Biomarkers Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Serum Cancer Biomarkers Sales by Regions 2014-2019 (K Units)
Table Global Serum Cancer Biomarkers Sales Market Share by Regions 2014-2019
Figure Global Serum Cancer Biomarkers Sales Market Share by Regions 2014-2019
Figure 2018 Global Serum Cancer Biomarkers Sales Market Share by Regions
Table Global Serum Cancer Biomarkers Revenue by Regions 2014-2019 (Million US$)
Table Global Serum Cancer Biomarkers Revenue Market Share by Regions 2014-2019
Figure Global Serum Cancer Biomarkers Revenue Market Share by Regions 2014-2019
Figure 2018 Global Serum Cancer Biomarkers Revenue Market Share by Regions
Table Global Serum Cancer Biomarkers Sales by Manufacturers (2014-2019) (K Units)
Table Global Serum Cancer Biomarkers Sales Share by Manufacturers (2014-2019)
Figure Global Serum Cancer Biomarkers Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Serum Cancer Biomarkers Revenue by Manufacturers (2014-2019) (Million USD)
Table Serum Cancer Biomarkers Revenue Share by Manufacturers (2014-2019)
Figure Serum Cancer Biomarkers Value Share by Manufacturers in 2018
Table Key Manufacturers Serum Cancer Biomarkers Price (2014-2019) (USD/Unit)
Table Serum Cancer Biomarkers Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Serum Cancer Biomarkers Product Type
Table Date of International Manufacturers Enter into Serum Cancer Biomarkers Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Serum Cancer Biomarkers Sales by Product (2014-2019) (K Units)
Table Global Serum Cancer Biomarkers Sales Share by Product (2014-2019)
Figure Global Serum Cancer Biomarkers Sales Market Share by Product (2014-2019)
Figure Global Serum Cancer Biomarkers Sales Market Share by Product in 2018
Table Global Serum Cancer Biomarkers Revenue by Product (2014-2019) (Million US$)
Table Global Serum Cancer Biomarkers Revenue Share by Product (2014-2019)
Figure Global Serum Cancer Biomarkers Revenue Market Share by Product (2014-2019)
Figure Global Serum Cancer Biomarkers Revenue Market Share by Product in 2018
Table Serum Cancer Biomarkers Price by Product 2014-2019 (USD/Unit)
Table Global Serum Cancer Biomarkers Sales by End User (2014-2019) (K Units)
Table Global Serum Cancer Biomarkers Sales Share by End User (2014-2019)
Figure Global Sales Serum Cancer Biomarkers Market Share by End User (2014-2019)
Figure Global Sales Serum Cancer Biomarkers Market Share by End User in 2018
Figure North America Serum Cancer Biomarkers Sales Growth Rate 2014-2019 (K Units)
Figure North America Serum Cancer Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
Table North America Serum Cancer Biomarkers Sales by Countries (2014-2019) (K Units)
Table North America Serum Cancer Biomarkers Sales Market Share by Countries (2014-2019)
Figure 2018 North America Serum Cancer Biomarkers Sales Market Share by Countries
Table North America Serum Cancer Biomarkers Revenue by Countries (2014-2019) (Million US$)
Table North America Serum Cancer Biomarkers Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Serum Cancer Biomarkers Revenue Market Share by Countries
Figure United States Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure United States Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Canada Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Table North America Serum Cancer Biomarkers Sales by Product (2014-2019) (K Units)
Table North America Serum Cancer Biomarkers Sales Market Share by Product (2014-2019)
Figure 2018 North America Serum Cancer Biomarkers Market Share by Product
Table North America Serum Cancer Biomarkers Sales by End User (2014-2019) (K Units)
Table North America Serum Cancer Biomarkers Sales Market Share by End User (2014-2019)
Figure 2018 North America Serum Cancer Biomarkers Market Share by End User
Figure Europe Serum Cancer Biomarkers Sales Growth Rate 2014-2019 (K Units)
Figure Europe Serum Cancer Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Serum Cancer Biomarkers Sales by Countries (2014-2019) (K Units)
Table Europe Serum Cancer Biomarkers Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Serum Cancer Biomarkers Sales Market Share by Countries
Table Europe Serum Cancer Biomarkers Revenue by Countries (2014-2019) (Million US$)
Table Europe Serum Cancer Biomarkers Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Serum Cancer Biomarkers Revenue Market Share by Countries
Figure Germany Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Germany Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure France Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure France Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure UK Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Italy Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Russia Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Serum Cancer Biomarkers Sales by Product (2014-2019) (K Units)
Table Europe Serum Cancer Biomarkers Sales Market Share by Product (2014-2019)
Figure 2018 Europe Serum Cancer Biomarkers Market Share by Product
Table Europe Serum Cancer Biomarkers Sales by End User (2014-2019) (K Units)
Table Europe Serum Cancer Biomarkers Sales Market Share by End User (2014-2019)
Figure 2018 Europe Serum Cancer Biomarkers Market Share by End User
Figure Asia Pacific Serum Cancer Biomarkers Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Serum Cancer Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Serum Cancer Biomarkers Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Serum Cancer Biomarkers Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Serum Cancer Biomarkers Sales Market Share by Countries
Table Asia Pacific Serum Cancer Biomarkers Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Serum Cancer Biomarkers Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Serum Cancer Biomarkers Revenue Market Share by Countries
Figure China Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure China Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Japan Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Korea Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure India Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure India Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Australia Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Serum Cancer Biomarkers Sales by Product (2014-2019) (K Units)
Table Asia Pacific Serum Cancer Biomarkers Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Serum Cancer Biomarkers Market Share by Product
Table Asia Pacific Serum Cancer Biomarkers Sales by End User (2014-2019) (K Units)
Table Asia Pacific Serum Cancer Biomarkers Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Serum Cancer Biomarkers Market Share by End User
Figure Central & South America Serum Cancer Biomarkers Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Serum Cancer Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Serum Cancer Biomarkers Sales by Countries (2014-2019) (K Units)
Table Central & South America Serum Cancer Biomarkers Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Serum Cancer Biomarkers Sales Market Share by Countries
Table Central & South America Serum Cancer Biomarkers Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Serum Cancer Biomarkers Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Serum Cancer Biomarkers Revenue Market Share by Countries
Figure Brazil Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Serum Cancer Biomarkers Sales by Product (2014-2019) (K Units)
Table Central & South America Serum Cancer Biomarkers Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Serum Cancer Biomarkers Market Share by Product
Table Central & South America Serum Cancer Biomarkers Sales by End User (2014-2019) (K Units)
Table Central & South America Serum Cancer Biomarkers Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Serum Cancer Biomarkers Market Share by End User
Figure Middle East and Africa Serum Cancer Biomarkers Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Serum Cancer Biomarkers Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Serum Cancer Biomarkers Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Serum Cancer Biomarkers Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Serum Cancer Biomarkers Sales Market Share by Countries
Table Middle East and Africa Serum Cancer Biomarkers Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Serum Cancer Biomarkers Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Serum Cancer Biomarkers Revenue Market Share by Countries
Figure GCC Countries Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Serum Cancer Biomarkers Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Serum Cancer Biomarkers Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Serum Cancer Biomarkers Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Serum Cancer Biomarkers Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Serum Cancer Biomarkers Market Share by Product
Table Middle East and Africa Serum Cancer Biomarkers Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Serum Cancer Biomarkers Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Serum Cancer Biomarkers Market Share by End User
Table Roche Company Details
Table Roche Serum Cancer Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Roche Recent Development
Table Pfizer Company Details
Table Pfizer Serum Cancer Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Novartis Company Details
Table Novartis Serum Cancer Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Abbott Company Details
Table Abbott Serum Cancer Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Abbott Recent Development
Table BD Company Details
Table BD Serum Cancer Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table BD Recent Development
Table Merck Company Details
Table Merck Serum Cancer Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Serum Cancer Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Serum Cancer Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Agilent Technologies Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Serum Cancer Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Serum Cancer Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Bristol-Myers Squibb Company Details
Table Novo Nordisk Company Details
Table Allergan Company Details
Table Gilead Company Details
Table Global Serum Cancer Biomarkers Sales Forecast by Regions 2019-2025 (K Units)
Table Global Serum Cancer Biomarkers Sales Market Share Forecast by Regions 2019-2025
Table Global Serum Cancer Biomarkers Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Serum Cancer Biomarkers Revenue Market Share Forecast by Regions 2019-2025
Table Global Serum Cancer Biomarkers Sales Forecast by Product 2019-2025 (K Units)
Table Global Serum Cancer Biomarkers Sales Market Share Forecast by Product 2019-2025
Table Global Serum Cancer Biomarkers Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Serum Cancer Biomarkers Revenue Market Share Forecast by Product 2019-2025
Table Global Serum Cancer Biomarkers Sales Forecast by End User 2019-2025 (K Units)
Table Global Serum Cancer Biomarkers Sales Market Share Forecast by End User 2019-2025
Figure North America Serum Cancer Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Serum Cancer Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Serum Cancer Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Serum Cancer Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Serum Cancer Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Serum Cancer Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Serum Cancer Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Serum Cancer Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Serum Cancer Biomarkers Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Serum Cancer Biomarkers Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Serum Cancer Biomarkers Value Chain
Table Serum Cancer Biomarkers Customers List
Table Serum Cancer Biomarkers Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
予測バイオマーカーの世界市場：市場規模・現状・予測 Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic.The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. In 2…- 予測バイオマーカーの世界市場：市場規模・現状・予測 Predictive biomarkers help to optimize therapy decisions, as they provide information on the likelihood of response to a given chemotherapeutic.The predictive biomarkers market is expected to register a fast growth over the forecast period owing to the increase in the prevalence rate of cancer. In 2…
- ゲノミクスバイオマーカーの世界市場：市場規模・現状・予測 A measurable DNA and/or RNA characteristic is an indicator of normal biologic processes, pathogenic processes, and/or response to a therapeutic or other interventions. A genomic biomarker can be used for measuring the expression, function, and regulation of a gene. These biomarkers have characterist…
- 世界の神経学的バイオマーカー市場：専門的調査 A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood gluco…
- バイオマーカーの世界市場：インサイト・予測 A biomarker, or biological marker is a measurable indicator of some biological state or condition. Biomarkers are often measured and evaluated to examine normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. Biomarkers are used in many scientifi…